Abstract:Background: The human CD19 antigen is expressed throughout B cell ontogeny with the exception of neoplastic plasma cells and a subset of normal plasma cells. CD19 plays a role in propagating signals from the B cell receptor and other receptors such as CXCR4 in mature B cells. Studies of CD19-deficient patients have confirmed its function during the initial stages of B cell activation and the production of memory B cells; however, its role in the later stages of B cell differentiation is unclear. Objective: Using B cells from a newly identified CD19-deficient individual, we investigated the role of CD19 in the generation and function of plasma cells using an in vitro differentiation model. Methods: Flow cytometry and long-read nanopore sequencing using locus-specific long-range amplification products were used to screen a patient with suspected primary immunodeficiency. Purified B cells from the patient and healthy controls were activated with CD40L, IL-21, IL-2, and anti-Ig, then transferred to different cytokine conditions to induce plasma cell differentiation. Subsequently, the cells were stimulated with CXCL12 to induce signalling through CXCR4. Phosphorylation of key downstream proteins including ERK and AKT was assessed by Western blotting. RNA-seq was also performed on in vitro differentiating cells. Results: Long-read nanopore sequencing identified the homozygous pathogenic mutation c.622del (p.Ser208Profs*19) which was corroborated by the lack of CD19 cell surface staining. CD19-deficient B cells that are predominantly naïve generate phenotypically normal plasma cells with expected patterns of differentiation-associated genes and normal levels of CXCR4. Differentiated CD19-deficient cells were capable of responding to CXCL12; however, plasma cells derived from naïve B cells, both CD19-deficient and sufficient, had relatively diminished signaling compared to those generated from total B cells. Additionally, CD19 ligation on normal plasma cells results in AKT phosphorylation. Conclusion: CD19 is not required for generation of antibody-secreting cells or the responses of these populations to CXCL12, but may alter the response other ligands that require CD19 potentially affecting localization, proliferation, or survival. The observed hypogammaglobulinemia in CD19-deficient individuals is therefore likely attributable to the lack of memory B cells.

Affinity alone does not drive long‐lived plasma cell differentiation

Lack of affinity signature for germinal center cells that have initiated plasma cell differentiation

New insights into the mechanisms regulating plasma cell survival and longevity

New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells

Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density

Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12

Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota

Plasma cell survival in the absence of B cell memory

Predicting plasma cell retention and loss over a lifetime

Plasma cell differentiation during the germinal center reaction

Plasma cell heterogeneity is driven by type of immune challenge

Antigen affinity discrimination is an intrinsic function of the B cell receptor.

Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy

Memory B cells and plasma cells: The differentiative continuum of humoral immunity

Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs

Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche

Discrimination of Membrane Antigen Affinity by B Cells Requires Dominance of Kinetic Proofreading over Serial Engagement.

The weakest link bridging germinal center B cells and follicular dendritic cells limits antibody affinity maturation

Reducing affinity as a strategy to boost immunomodulatory antibody agonism